Marizyme, Inc., a multi-technology Life Science company, engages in the research, manufacture, and commercialization of medical devices, diagnostics, and products to address clinical needs in the United States, Europe, and Asia. The company operates as a medical technology company that delivers solutions for coronary artery bypass graft (CABG) surgery. Its product portfolio includes DuraGraft, a vascular graft storage and flushing solution; and Krillase, an enzyme that acts to break protein bond...
